HomeBest options strategy › RGNX

Best Options Strategy for RGNX

By Yojana Mandon · Updated 2026-08-14 · 2 min read · Risk disclaimer

Looking for the best options strategy for REGENXBIO Inc. (RGNX)? There is no single answer — the right play depends on your outlook, your risk tolerance and current implied volatility. Below, our free engine shows the highest-scoring defined-risk strategy on the live RGNX option chain right now, and a simple map from your view on RGNX to the strategy that fits it. Model any of them in the calculator before you trade.

About RGNX

REGENXBIO Inc. (RGNX) is a major company in Biotechnology. Options traders on RGNX tend to watch , since these can drive large moves in the share price.

About REGENXBIO Inc.

REGENXBIO Inc. is a biotechnology company developing gene therapies designed to correct genetic disorders by delivering functional genes to defective cells. The company's pipeline relies on NAV Technology Platform, a proprietary system using adeno-associated viruses to carry genetic material into target tissues. Its clinical candidates address serious conditions including wet age-related macular degeneration and diabetic retinopathy through ABBV-RGX-314, Duchenne muscular dystrophy via RGX-202, and two forms of mucopolysaccharidosis through RGX-121 and RGX-111. Beyond developing its own products, the company generates revenue by licensing the NAV platform to other pharmaceutical firms and biotechnology companies seeking to build their own gene therapy programs.

The company operates primarily through product development and platform licensing agreements. Its most advanced partnership involves AbbVie, which is advancing ABBV-RGX-314 in clinical trials. REGENXBIO has also partnered with Nippon Shinyaku to commercialize RGX-121 and RGX-111 outside the United States, expanding its geographic reach through these arrangements. Founded in 2008 and based in Rockville, Maryland, the…

Today's top-scoring strategy for RGNX

Our engine ranks defined-risk strategies on the live RGNX chain by probability of profit and risk/reward, then surfaces the best-scoring one. It is an educational illustration, not advice.

Iron Condor neutral
Price: $10.61Implied volatility: 121%Expiration: 2026-09-18 (34d)
ActionQtyTypeStrikePremium
BuyPUT$8$0.50
SellPUT$9$1.27
SellCALL$13$1.35
BuyCALL$15$0.43
P/L at expiry vs today At expiry Today ±1σ
$4$12$19
Max Profit
$170
Max Loss
−$31
Net Credit (received)
$169
Breakeven(s)
$14.70
Position Greeks
Δ
−3.86
Γ
−3.673
Θ
0.83
ν
−0.47
Time decay (price held)
Implied-volatility skew

Simulation

Forward simulation of 6,000 lognormal price paths to expiration — not a historical backtest.

Win rate
86%
Mean P/L
$100
Median
$94
Exp. move (1σ)
37%
5th pct
−$31
25th pct
$69
75th pct
$170
95th pct
$170

Strategy analysis

Simulated price paths (time × price)
now $11BE $15$5$12$180d17d34d
$-28$69$167

Greeks vs price

Δ — $ P/L per $1 move in the underlying (share-equivalent exposure).
Θ — $ P/L per day from time decay.
ν — $ P/L per +1% in implied volatility.
Γ — how fast delta changes per $1 move.

Price × volatility (today)

−30%−15%IV+15%+30%
$13$90$84$80$75$72
$13$99$91$85$80$76
$12$107$97$90$84$79
$12$114$103$94$87$82
$11$119$107$97$90$84
$11$122$110$100$92$86
$10$123$111$102$94$88
$10$121$110$102$95$89
$9$116$108$101$95$90
$8$110$105$99$94$90
$8$102$100$96$93$89
Analyze RGNX in the calculator → Share this pick ↗

Live scan from 2026-08-14 · quotes delayed ~15 minutes

Historical backtest: how a Iron Condor on RGNX would have performed

We approximated a Iron Condor on RGNX, entered repeatedly over the past year (92 historical entries, each held to expiration) with Black-Scholes-modelled entry premiums. Here is how that would have played out on real RGNX price history — an educational backtest, not a prediction of future returns.

Trades
92
Win rate
0%
Total P/L
-$33
Avg return on risk
-15%
Best trade
$0
Worst trade
-$33
Cumulative P/L over the backtest

Approximate: entry premiums are modelled with Black-Scholes from trailing realised volatility, held to expiration and settled against the real historical close. Real fills, implied volatility and slippage differ — treat it as directional context, not exact returns.

Implied volatility

RGNX is currently trading with high implied volatility, which makes its options expensive — and attractive to sell. On the options we scanned that was around 121% implied volatility, and higher implied volatility means richer premiums and wider expected moves.

Options on RGNX currently price in about 121% implied volatility, versus roughly 84% the stock has actually realised over the past month. That makes options relatively expensive — an edge for strategies that sell premium, such as credit spreads and iron condors.

RGNX's IV Rank is 57/100: implied volatility sits 57% of the way between its 16-day low (82%) and high (151%), and is above 41% of recorded days. Premium sits around its usual level for this stock.

Off that volatility, the options market is pricing a move of about ±$3.93 (±37%) in RGNX by 2026-09-18 — a range of roughly $6.68 to $14.54. Strikes inside that band hold most of the premium and see most of the action.

Across strikes, downside puts on RGNX trade at a higher implied volatility than upside calls — the market is paying up for crash protection. That skew favours selling put spreads or buying calls over symmetric trades.

RGNX options chain highlights: open interest, volume and skew

The live RGNX options chain shows a put/call open-interest ratio of 0.54 (bullish-leaning (more calls)), with at-the-money implied volatility near 153.7%. Open interest clusters at the $12 call — a common resistance "wall" — and the $10 put, a support "wall": the strikes option writers are most exposed to into expiration.

Put/Call OI
0.54
Put/Call volume
1.75
ATM IV
153.7%
Put–call IV skew
-34.6
Call OI wall
$12 · 268
Put OI wall
$10 · 302
Most active call
$9 · 5
Most active put
$9 · 16
Most active strikes (volume)
$8$11$15
Calls   Puts

Snapshot of open interest, volume and implied volatility for the nearest scanned expiration — context, not a trading signal.

RGNX insider trading activity (SEC Form 4)

Open-market insider transactions at RGNX over roughly the last six months, from SEC Form 4 filings. Open-market buys are the rarer, more telling signal — routine selling under pre-arranged plans is common, so read a net-selling figure with that in mind.

Open-market buys
0 · —
Open-market sells
5 · $940K
Net (buy − sell)
−$940K
InsiderActionSharesValueDate
PAKOLA STEVESell2,161$29K2026-07-02
PAKOLA STEVESell36,725$472K2026-07-01
PAKOLA STEVESell19,608$216K2026-06-29
PAKOLA STEVESell15,309$169K2026-05-11
PAKOLA STEVESell5,124$53K2026-03-10

Source: SEC Form 4 filings via Finnhub. Open-market purchases (P) and sales (S) only — grants, option exercises, gifts and tax withholding are excluded. Informational context, not investment advice.

Earnings & IV crush

RGNX's next earnings report is due around November 5, 2026. Options that expire after it price in a binary move, so their implied volatility is elevated and usually collapses right after the announcement — an "IV crush". If your expiration falls before this date, the trade sidesteps the event.

Key figures

Market cap
$672M
Beta (vs market)
0.94
52-week range
$5.46–$16.19 (48% up the range)
Short interest
18.0% of float · 2.9 days to cover

With 18.0% of RGNX's float sold short, squeeze and gap risk are elevated — one reason its options can stay expensive.

Other strong setups for RGNX

If your view on RGNX differs, these also scored well in the latest scan:

How to choose an options strategy for RGNX

Start with your outlook on RGNX, then match it to a defined-risk structure. Here are the most common choices and when each makes sense:

Bullish

You expect RGNX to rise

Buy a call for leverage with capped risk, or a bull call spread to lower the cost and breakeven when you have a target price.

Long Call → Bull Call Spread →

Bearish

You expect RGNX to fall

Buy a put to profit from a decline with defined risk, or a bear put spread to cheapen the trade when you expect a measured move down.

Long Put → Bear Put Spread →

Neutral

You expect RGNX to trade in a range

Sell an iron condor to collect premium while RGNX stays between two strikes, or write a covered call against shares you already own.

Iron Condor → Covered Call →

⧉ Embed this free calculator on your site →

How we pick the best strategy

For each ticker we pull the live option chain, build every supported strategy around the at-the-money strikes, and score them on probability of profit, risk/reward and capital efficiency — favouring defined-risk structures where the maximum loss is known up front. Methodology →

Open RGNX in the free calculator →

Frequently asked questions

What is the best options strategy for RGNX?

It depends on your outlook. Bullish traders often use a long call or bull call spread on RGNX; bearish traders a long put or bear put spread; neutral traders an iron condor or covered call. Our live scan above shows the current highest-scoring defined-risk play.

Are RGNX options liquid enough to trade?

REGENXBIO Inc. (RGNX) is among the most actively-traded US options, which usually means tight bid/ask spreads and plenty of strikes and expirations — though you should always check the open interest and spread on the exact contract.

How much money do I need to trade RGNX options?

Buying a single RGNX call or put can cost as little as the premium (often one to a few hundred dollars), while income strategies like a cash-secured put need enough capital to buy 100 shares if assigned.

Is this financial advice?

No. Everything here is educational and uses delayed, third-party data. It is not a recommendation to trade RGNX or any security. Do your own research.

What does REGENXBIO Inc. do?

REGENXBIO Inc. (RGNX) operates in the Biotechnology industry. The "About REGENXBIO Inc." section above gives a fuller picture of what the company does and how it earns money.

Does REGENXBIO Inc. pay a dividend?

We don't show a confirmed dividend yield for REGENXBIO Inc. here, so treat it as uncertain: before writing calls, check its current dividend and ex-dividend date with your broker — an approaching ex-dividend date can trigger early assignment on in-the-money short calls.

When does REGENXBIO Inc. next report earnings?

REGENXBIO Inc.'s next earnings are expected around November 5, 2026. Implied volatility usually climbs into the report and drops sharply afterwards (IV crush) — important for any options position held over the date.

Price trend

Short term · 1M
▼ -3.9%
Mid term · 3M
▲ +72.4%
Long term · 1Y
▲ +22.1%

Tickers related to RGNX

Comparing RGNX with similar names can help you choose the best options strategy:

QUREuniQure N.V.RAREUltragenyx Pharmaceutical Inc.

Company information

Headquarters
9804 Medical Center Drive, Rockville, MD, 20850, United States
Industry
Biotechnology
Employees
371
CEO
Mr. Curran M. Simpson M.S.
Phone
240 552 8181
Website
www.regenxbio.com

Best Options Strategy by Ticker →

Educational use only. Quotes are delayed ~15 minutes and nothing here is financial advice. Options trading involves substantial risk of loss. Privacy · Terms.